RVMD Revolution Medicines, Inc.

NASDAQ
$203.77

Revolution Medicines, Inc. (RVMD) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Moderately bearish Selling ran elevated versus RVMD's own trailing one-year pace, with 98% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 8 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
10
85 transactions
Purchases
$0
0 shares
Sales
$94.5M
560,494 shares
Net activity
-$94.5M
purchases less sales

How much of that selling was preplanned? 98% planned / 2% discretionary

10b5-1 plan sales $92.5M 72 transactions · 549,879 shares
Discretionary sales $2.0M 13 transactions · 10,615 shares

Largest single sale: $18.0M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Kim Lorence H. 7 fills Director Sell 10b5-1 17,090 $209.82 $3.6M 16,384 −51.1% of holding
Kim Lorence H. 7 fills Director Sell 10b5-1 56,000 $203.24 $11.4M 72,790 −43.5% of holding
GOLDSMITH MARK A 6 fills See Remarks Sell 10b5-1 80,000 $209.20 $16.7M 342,202 −18.9% of holding
Cislini Jeff 6 fills General Counsel Sell 10b5-1 56,894 $209.24 $11.9M 109,401 −34.2% of holding
GOLDSMITH MARK A 12 fills See Remarks Sell 6,000 $209.20 $1.3M 64,247 −8.5% of holding
Patel Sushil 9 fills Director Sell 10b5-1 5,580 $187.99 $1.0M 26,936 −17.2% of holding
Anders Jack 4 fills Chief Financial Officer Sell 10b5-1 20,000 $168.33 $3.4M 138,716 −12.6% of holding
Horn Margaret A Chief Operating Officer Sell 10b5-1 29,600 $160.12 $4.7M 154,647 −16.1% of holding
GOLDSMITH MARK A See Remarks Sell 10b5-1 10,020 $156.12 $1.6M 267,330 −3.6% of holding
Mancini Anthony See Remarks Sell 4,615 $156.12 $720.5K 49,975 −8.5% of holding
Kelsey Stephen Michael See Remarks Sell 10b5-1 4,175 $156.12 $651.8K 291,876 −1.4% of holding
Anders Jack Chief Financial Officer Sell 10b5-1 2,722 $156.12 $425.0K 123,269 −2.2% of holding
Cislini Jeff General Counsel Sell 10b5-1 2,157 $156.12 $336.7K 56,521 −3.7% of holding
Horn Margaret A Chief Operating Officer Sell 10b5-1 60,400 $160.17 $9.7M 158,222 −27.6% of holding
Horn Margaret A 7 fills Chief Operating Officer Sell 10b5-1 10,000 $148.01 $1.5M 166,907 −5.7% of holding
Mancini Anthony 3 fills See Remarks Sell 10b5-1 3,121 $153.99 $480.6K 56,821 −5.2% of holding
Mancini Anthony 3 fills See Remarks Sell 10b5-1 3,120 $132.41 $413.1K 55,849 −5.3% of holding
GOLDSMITH MARK A See Remarks Sell 10b5-1 120,000 $150.09 $18.0M 276,698 −30.2% of holding
Mancini Anthony 5 fills See Remarks Sell 10b5-1 37,450 $95.56 $3.6M 90,050 −29.4% of holding
Cislini Jeff General Counsel Sell 10b5-1 1,163 $97.44 $113.3K 58,518 −1.9% of holding
GOLDSMITH MARK A See Remarks Sell 10b5-1 12,871 $99.48 $1.3M 276,698 −4.4% of holding
Horn Margaret A Chief Operating Officer Sell 10b5-1 4,583 $99.48 $455.9K 157,570 −2.8% of holding
Kelsey Stephen Michael See Remarks Sell 10b5-1 4,302 $99.48 $428.0K 295,398 −1.4% of holding
Anders Jack Chief Financial Officer Sell 10b5-1 2,753 $99.48 $273.9K 125,512 −2.1% of holding
Wei Lin Chief Medical Officer Sell 10b5-1 2,073 $99.48 $206.2K 101,366 −2% of holding
Wang Xiaolin See Remarks Sell 10b5-1 2,010 $99.48 $200.0K 116,063 −1.7% of holding
Cislini Jeff General Counsel Sell 10b5-1 1,795 $99.48 $178.6K 59,681 −2.9% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.